Glucotrack (GCTK) Cost of Revenue (2016 - 2025)

Glucotrack (GCTK) recorded quarterly Cost of Revenue of $120000.0 in Q3 2025, down 34.07% on a QoQ basis from $182000.0 in Q2 2025, and down 4.0% year-over-year from $125000.0 in Q3 2024.

Glucotrack (GCTK) Cost of Revenue (2016 - 2025) Analysis & Trends

Glucotrack has disclosed Cost of Revenue across 8 years of filings, most recently posting $120000.0 for Q3 2025.

  • Quarterly Cost of Revenue fell 4.0% year-over-year to $120000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $555000.0 (up 86.24% YoY) and the FY2023 annual result came in at $122000.0, changed N/A from the prior year.
  • Cost of Revenue slipped to $120000.0 in Q3 2025, from $182000.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $182000.0 in Q2 2025 and troughed at $3000.0 in Q4 2021.
  • A 3-year average of $96000.0 and a median of $113000.0 in 2021 frame the typical range for Cost of Revenue.
  • Biggest YoY gain for Cost of Revenue was 108.11% in 2021; the steepest drop was 74.73% in 2021.
  • Tracing GCTK's Cost of Revenue over 3 years: stood at $3000.0 in 2021, then soared by 4066.67% to $125000.0 in 2024, then decreased by 4.0% to $120000.0 in 2025.
  • Business Quant data shows GCTK's Cost of Revenue at $120000.0 in Q3 2025, $182000.0 in Q2 2025, and $128000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 940.30 Mn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 2.56 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 5.51 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 540.43 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 548.50 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 64.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 346.10 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 303.50 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 1.81 Bn
10 Glucotrack 4.26 -7.38 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 120,000.00
Sep 30, 2025 120,000.00
Jun 30, 2025 182,000.00
Jun 30, 2025 182,000.00
Mar 31, 2025 128,000.00
Mar 31, 2025 128,000.00
Sep 30, 2024 125,000.00
Sep 30, 2024 125,000.00
Jun 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 70,000.00
Mar 31, 2024 70,000.00
Dec 31, 2021 3,000.00
Dec 31, 2021 3,000.00
Sep 30, 2021 113,000.00
Sep 30, 2021 113,000.00
Mar 31, 2021 23,000.00
Mar 31, 2021 23,000.00
Dec 31, 2020 -37,000.00
Dec 31, 2020 -37,000.00